scispace - formally typeset
N

Nicholas van Bruggen

Researcher at Genentech

Publications -  46
Citations -  7317

Nicholas van Bruggen is an academic researcher from Genentech. The author has contributed to research in topics: Vascular endothelial growth factor & Angiogenesis. The author has an hindex of 26, co-authored 44 publications receiving 6683 citations. Previous affiliations of Nicholas van Bruggen include Hoffmann-La Roche.

Papers
More filters
Journal ArticleDOI

Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover

TL;DR: The responses to exogenous VEGF observed in two distinct model systems and species indicate that a slow-release formulation of V EGF, applied locally at the site of bone damage, may prove to be an effective therapy to promote human bone repair.
Journal ArticleDOI

VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain

TL;DR: VEGF can markedly enhance angiogenesis in the ischemic brain and reduce neurological deficits during stroke recovery and that inhibition of VEGF at the acute stage of stroke may reduce the BBB permeability and the risk of hemorrhagic transformation after focal cerebral ischemia.
Journal ArticleDOI

Molecular imaging in drug development

TL;DR: The applications of molecular Imaging in drug development are reviewed, highlighting successes and identifying key challenges that need to be addressed for successful integration of molecular imaging into the drug development process.
Journal ArticleDOI

Bv8 regulates myeloid-cell-dependent tumour angiogenesis

TL;DR: Bv8 modulates mobilization of CD11b+Gr1+ cells from the bone marrow during tumour development and also promotes angiogenesis locally, which is additive to those of anti-Vegf antibodies or cytotoxic chemotherapy.
Journal ArticleDOI

Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes

TL;DR: This study shows that metastatic tumors examined overexpress granulocyte-colony stimulating factor (G-CSF), which expands and mobilizes Ly6G+Ly6C+ granulocytes and facilitates their subsequent homing at distant organs even before the arrival of tumor cells.